Acadia Pharmaceuticals (ACAD) Invested Capital (2010 - 2012)

Acadia Pharmaceuticals' Invested Capital history runs 3 years deep, the most recent figure standing at $22000.0 for Q1 2012.

• On a quarterly basis, Invested Capital changed N/A year-over-year to $22000.0 in Q1 2012; TTM through Dec 2012 was $22000.0, a 79.82% decrease from a year earlier, with the FY2011 full-year figure at $32000.0, down 58.97% from the prior year.
• Invested Capital slipped to $22000.0 in Q1 2012 per ACAD's latest filing, from $32000.0 in the prior quarter.
• Across five years, Invested Capital topped out at $78000.0 in Q4 2010 and bottomed at $22000.0 in Q1 2012.
• The 3-year median for Invested Capital is $37000.0 (2011), against an average of $41800.0.
• Biggest YoY gain for Invested Capital was 58.97% in 2011; the steepest drop was 58.97% in 2011.
• Year by year, Invested Capital stood at $78000.0 in 2010, then sank by 58.97% to $32000.0 in 2011, then tumbled by 31.25% to $22000.0 in 2012.
• Per Business Quant, the three latest ACAD Invested Capital figures stand at $22000.0 (Q1 2012), $32000.0 (Q4 2011), and $37000.0 (Q3 2011).